These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 17475725)

  • 41. Comparison of buprenorphine and methadone effects on opiate self-administration in primates.
    Mello NK; Bree MP; Mendelson JH
    J Pharmacol Exp Ther; 1983 May; 225(2):378-86. PubMed ID: 6188822
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Adolescent opioid abuse.
    O'Brien CP
    Arch Gen Psychiatry; 2005 Oct; 62(10):1165. PubMed ID: 16203962
    [No Abstract]   [Full Text] [Related]  

  • 43. [Outcome of a substitution therapy program in an outpatient treatment setting of a psychiatric hospital].
    Unglaub W; Loncarek E; Wismath M; Johann M; Wodarz N; Klein H
    Psychiatr Prax; 2004 Nov; 31 Suppl 1():S26-8. PubMed ID: 15570492
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Promise of extended-release naltrexone is a red herring.
    Bart G
    Lancet; 2011 Aug; 378(9792):663; author reply 663-4. PubMed ID: 21856474
    [No Abstract]   [Full Text] [Related]  

  • 45. Buprenorphine for human immunovirus-positive opiate-dependent patients.
    Montoya ID; Umbricht A; Preston KL
    Biol Psychiatry; 1995 Jul; 38(2):135-6. PubMed ID: 7578651
    [No Abstract]   [Full Text] [Related]  

  • 46. Cocaine abuse among methadone-maintained patients.
    Oliveto A; Kosten T; Schottenfeld R; Ziedonis D
    Am J Psychiatry; 1993 Nov; 150(11):1755. PubMed ID: 8214197
    [No Abstract]   [Full Text] [Related]  

  • 47. Psychosocial factors in outcome in two opiate addiction treatments.
    Grey C; Osborn E; Reznikoff M
    J Clin Psychol; 1986 Jan; 42(1):185-9. PubMed ID: 3950006
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Naltrexone.
    Kleber HD
    J Subst Abuse Treat; 1985; 2(2):117-22. PubMed ID: 3007777
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Psychosocial adjustment, modality choice, and outcome in naltrexone versus methadone treatment.
    Osborn E; Grey C; Reznikoff M
    Am J Drug Alcohol Abuse; 1986; 12(4):383-8. PubMed ID: 3826024
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Preferences for clinic privileges, retail items and social activities in an outpatient buprenorphine treatment program.
    Amass L; Bickel WK; Crean JP; Higgins ST; Badger GJ
    J Subst Abuse Treat; 1996; 13(1):43-9. PubMed ID: 8699542
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Clonidine versus methadone for opiate detoxification.
    Washton AM; Resnick RB
    Lancet; 1980 Dec; 2(8207):1297. PubMed ID: 6108466
    [No Abstract]   [Full Text] [Related]  

  • 52. Medication Treatment For Substance Abuse.
    Rosenberg L
    Health Aff (Millwood); 2019 Apr; 38(4):695. PubMed ID: 30933586
    [No Abstract]   [Full Text] [Related]  

  • 53. Methadone maintenance treatment in opiate dependence: a review.
    Farrell M; Ward J; Mattick R; Hall W; Stimson GV; des Jarlais D; Gossop M; Strang J
    BMJ; 1994 Oct; 309(6960):997-1001. PubMed ID: 7950725
    [No Abstract]   [Full Text] [Related]  

  • 54. Program changes and retention on methadone.
    Maddux JF; Vogtsberger KN; Desmond DP; Esquivel M
    J Subst Abuse Treat; 1993; 10(6):585-8. PubMed ID: 8308944
    [No Abstract]   [Full Text] [Related]  

  • 55. Strategies to improve compliance with narcotic antagonists.
    Kosten TR; Kleber HD
    Am J Drug Alcohol Abuse; 1984; 10(2):249-66. PubMed ID: 6475891
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Conversation with Walter Ling.
    Ling W
    Addiction; 2015 Jan; 110(1):14-8. PubMed ID: 25322681
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Methadone treatment for opiate addicts.
    Sorensen JL
    BMJ; 1996 Aug; 313(7052):245-6. PubMed ID: 8704526
    [No Abstract]   [Full Text] [Related]  

  • 58. Heroin-assisted treatment: no difference in treatment retention.
    Al-Adwani A; Nahata R
    Br J Psychiatry; 2007 Nov; 191():458; author reply 458. PubMed ID: 17978338
    [No Abstract]   [Full Text] [Related]  

  • 59. Models for treating tuberculosis in narcotic-addicted patients.
    Newman RG; DesJarlais DC
    J Subst Abuse Treat; 1994; 11(1):61-2. PubMed ID: 8201635
    [No Abstract]   [Full Text] [Related]  

  • 60. NAOMI--her time has come. North American Opiate Medication Initiative.
    Schechter MT
    J Urban Health; 2002 Jun; 79(2):164-5. PubMed ID: 12023491
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.